Publications by authors named "Donna Shaffer"

Claim this Profile
P
Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malaria.
Ruth D Ellis, Yimin Wu, Laura B Martin, Donna Shaffer, Kazutoyo Miura

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial.
Anna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, Daniel Elwood, Catherine J Larsson, Donna Shaffer

J Infect Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single dose of the DENV-1 candidate vaccine rDEN1Δ30 is strongly immunogenic and induces resistance to a second dose in a randomized trial.
Anna P Durbin, Stephen S Whitehead, Donna Shaffer, Dan Elwood, Kimberli Wanionek

PLoS Negl Trop Dis· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the understanding of subjects receiving a candidate malaria vaccine in the United States and Mali.
Ruth D Ellis, Issaka Sagara, Anna Durbin, Alassane Dicko, Donna Shaffer

Am J Trop Med Hyg· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults.
Ruth D Ellis, Laura B Martin, Donna Shaffer, Carole A Long, Kazutoyo Miura

PLoS One· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals.
Ruth D Ellis, Gregory E D Mullen, Mark Pierce, Laura B Martin, Kazutoyo Miura, Donna Shaffer

Vaccine· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.
Yimin Wu, Ruth D Ellis, Donna Shaffer, Erica Fontes, Elissa M Malkin

PLoS One· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis